Food Science and Technology Department
Department of Food Science and Technology: Faculty Publications
ORCID IDs
Document Type
Article
Date of this Version
4-2019
Citation
Gut (April 2018) 67(4): 672–678
doi: 10.1136/gutjnl-2016-313413
Abstract
Objective: Recent evidence suggests that antibiotic use, which alters the gut microbiome, is associated with an increased risk of colorectal cancer. However, the association between antibiotic use and risk of colorectal adenoma, the precursor for the majority of colorectal cancers, has not been investigated.
Design: We prospectively evaluated the association between antibiotic use at age 20–39 and 40–59 (assessed in 2004) and recent antibiotic use (assessed in 2008) with risk of subsequent colorectal adenoma among 16,642 women aged ≥ 60 enrolled in the Nurses’ Health Study who underwent at least one colonoscopy through 2010. We used multivariate logistic regression to calculate odds ratios (ORs) and 95% confidence intervals (CIs).
Results: We documented 1,195 cases of adenoma. Increasing duration of antibiotic use at age 20–39 (Ptrend = 0.002) and 40–59 (Ptrend = 0.001) was significantly associated with an increased risk of colorectal adenoma. Compared to non-users, women who used antibiotics for ≥ 2 months between age 20–39 had a multivariable OR of 1.36 (95% CI: 1.03–1.79). Women who used ≥ 2 months of antibiotics between age 40–59 had a multivariable OR of 1.69 (95% CI: 1.24–2.31). The associations were similar for low-risk vs. high-risk adenomas (size ≥ 1 cm, or with tubulovillous/villous histology, or ≥ 3 detected lesions), but appeared modestly stronger for proximal compared with distal adenomas. In contrast, recent antibiotic use within the past 4 years was not associated with risk of adenoma (Ptrend = 0.44).
Conclusions: Long-term antibiotic use in early to middle adulthood was associated with increased risk of colorectal adenoma.
Included in
Digestive System Diseases Commons, Food Science Commons, Medical Microbiology Commons, Medical Pathology Commons, Neoplasms Commons, Oncology Commons, Pharmacy and Pharmaceutical Sciences Commons